News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
80,982 Results
Type
Article (2349)
Company Profile (20)
Press Release (78613)
Section
Business (35603)
Career Advice (52)
Deals (5191)
Drug Delivery (8)
Drug Development (10390)
Employer Resources (14)
FDA (1716)
Job Trends (1977)
News (50622)
Policy (2775)
Tag
Academia (180)
Accelerated approval (1)
Adcomms (3)
Allergies (9)
Alliances (3116)
ALS (2)
Alzheimer's disease (220)
Antibody-drug conjugate (ADC) (11)
Approvals (1739)
Artificial intelligence (20)
Autoimmune disease (3)
Automation (2)
Bankruptcy (24)
Best Places to Work (1820)
Biosimilars (6)
Biotechnology (13)
Bladder cancer (20)
Brain cancer (3)
Breast cancer (43)
Cancer (370)
Cardiovascular disease (26)
Career advice (46)
Career pathing (1)
CAR-T (12)
Cell therapy (40)
Cervical cancer (5)
Clinical research (9136)
Collaboration (59)
Compensation (111)
Complete response letters (1)
COVID-19 (246)
CRISPR (1)
C-suite (6)
Cystic fibrosis (5)
Data (423)
Depression (6)
Diabetes (38)
Diagnostics (856)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (10)
Drug pricing (8)
Duchenne muscular dystrophy (8)
Earnings (30693)
Editorial (3)
Employer branding (3)
Employer resources (10)
Events (9906)
Executive appointments (35)
FDA (1959)
Frontotemporal dementia (2)
Funding (56)
Gene editing (4)
Generative AI (3)
Gene therapy (35)
GLP-1 (98)
Government (326)
Guidances (107)
Healthcare (2485)
Huntington's disease (1)
IgA nephropathy (1)
Immunology and inflammation (12)
Indications (3)
Infectious disease (267)
Inflammatory bowel disease (9)
Influenza (7)
Intellectual property (10)
Interviews (6)
IPO (3793)
IRA (2)
Job creations (261)
Job search strategy (41)
Kidney cancer (2)
Labor market (9)
Layoffs (49)
Legal (448)
Liver cancer (14)
Lung cancer (77)
Lymphoma (32)
Management (4)
Manufacturing (18)
MASH (16)
Medical device (1970)
Medtech (1970)
Mergers & acquisitions (1461)
Metabolic disorders (99)
Multiple sclerosis (10)
NASH (2)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (284)
NextGen: Class of 2025 (590)
Non-profit (366)
Now hiring (3)
Obesity (45)
Opinion (5)
Ovarian cancer (10)
Pain (8)
Pancreatic cancer (9)
Parkinson's disease (25)
Patents (19)
Patient recruitment (10)
Peanut (7)
People (2684)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (2162)
Phase II (3872)
Phase III (3708)
Pipeline (596)
Policy (4)
Postmarket research (366)
Preclinical (654)
Press Release (12)
Prostate cancer (20)
Radiopharmaceuticals (25)
Rare diseases (42)
Real estate (317)
Recruiting (6)
Regulatory (2216)
Reports (10)
Research institute (159)
Resumes & cover letters (6)
Rett syndrome (1)
RNA editing (1)
RSV (8)
Schizophrenia (10)
Series A (4)
Series B (6)
Sickle cell disease (11)
Special edition (4)
Spinal muscular atrophy (9)
Sponsored (1)
Startups (192)
Stomach cancer (2)
Supply chain (6)
Tariffs (2)
The Weekly (1)
Vaccines (73)
Venture capitalists (7)
Weight loss (20)
Women's health (2)
Worklife (2)
Date
Today (41)
Last 7 days (263)
Last 30 days (538)
Last 365 days (5266)
2025 (1967)
2024 (5859)
2023 (6457)
2022 (7674)
2021 (8029)
2020 (7457)
2019 (5498)
2018 (4241)
2017 (3887)
2016 (3166)
2015 (4105)
2014 (2908)
2013 (1768)
2012 (2244)
2011 (2702)
2010 (2233)
Location
Africa (48)
Alabama (6)
Alaska (1)
Arizona (10)
Asia (4641)
Australia (809)
California (1061)
Canada (271)
China (67)
Colorado (58)
Connecticut (39)
Delaware (40)
Europe (10512)
Florida (139)
Georgia (28)
Idaho (3)
Illinois (64)
India (2)
Indiana (78)
Japan (29)
Kansas (12)
Kentucky (4)
Louisiana (4)
Maine (12)
Maryland (155)
Massachusetts (727)
Michigan (30)
Minnesota (64)
Missouri (11)
Montana (2)
Nebraska (2)
Nevada (6)
New Hampshire (16)
New Jersey (380)
New Mexico (1)
New York (255)
North Carolina (161)
Northern California (493)
Ohio (34)
Oregon (4)
Pennsylvania (307)
South America (116)
South Carolina (2)
Southern California (443)
Tennessee (14)
Texas (146)
United States (3964)
Utah (37)
Virginia (11)
Washington D.C. (3)
Washington State (133)
Wisconsin (5)
80,982 Results for "42".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rockwell Medical to Exhibit at DialysisTechConneXion42 in Booth# 112
March 11, 2025
·
4 min read
Press Releases
Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering
March 10, 2025
·
5 min read
Press Releases
Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering
March 7, 2025
·
5 min read
Press Releases
mRNA Therapeutics Market Size to Worth USD 42.64 Billion by 2034
February 26, 2025
·
1 min read
Press Releases
U.S. Intravenous Immunoglobulin Market Size to Hit USD 14.42 Billion by 2033
February 26, 2025
·
1 min read
Press Releases
Endovascular Engineering Raises $42 Million in Series B Financing to Advance the Treatment of Pulmonary Embolism
February 19, 2025
·
4 min read
Press Releases
Defence Closes Second Tranche of Fully Subscribed Financing Totaling $4.2 Million
January 31, 2025
·
4 min read
Press Releases
Pharmaceutical Water Market Size to Soar from USD 42.26 Bn in 2024 to USD 107.15 Bn by 2034
February 13, 2025
·
1 min read
Press Releases
M42 signals genomics expansion with strategic partnership with Uzbekistan’s Ministry of Health on the Uzbek Genome Program
January 29, 2025
·
3 min read
Ascletis Announces Strategic Decisions on FXR agonist ASC42
Ascletis Pharma Inc. announces the strategic decisions on farnesoid X receptor agonist ASC42.
April 3, 2024
·
2 min read
1 of 8,099
Next
